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SUMMARY 
A working group set up by the Finnish Ministry of Social Affairs and Health has drawn up national 
guidelines for the provision of pharmacotherapy in public and private social and health care units. 
The purpose of the Safe pharmacotherapy guidelines is to harmonise the principles for the provision 
of pharmacotherapy, to clarify the division of responsibilities related to its provision, and to deﬁ ne 
the minimum requirements that must be complied with in all units providing pharmacotherapy. The 
guidelines also give examples of good practices in pharmacotherapy. The development needs that 
necessitated the preparation of the guidelines are related, above all, to the deﬁ nition of questions of 
responsibility in pharmacotherapy in different sectors, harmonisation of licence practices, induction 
of staff, and ensuring and maintaining the knowledge and skills in pharmacotherapy.
The general guidelines and principles for pharmacotherapy are the same for all public and private 
social and health care units and well as for establishments providing pharmacotherapy in other areas. 
According to the guidelines the provision of pharmacotherapy is based on a pharmacotherapy plan 
drawn up in the unit or workplace, that serves as the tool for deﬁ nition and management of the fol-
lowing sub-areas in pharmacotherapy:
Content and methods of pharmacotherapy • 
Ensuring and maintaining the knowledge and skills in pharmacotherapy• 
Personnel’s responsibilities, obligations and division of labour• 
Licence practices• 
Pharmaceutical service: ordering, storing and manufacture of medicines, making them • 
ready for use, returning of medicines, information, guidance and advice 
Distribution and administration of medicines • 
Informing and advising patients• 
Evaluation of the effectiveness of pharmacotherapy • 
Documentation and ﬂ ow of information• 
Systems for monitoring and feedback • 
Pharmacotherapy is a health care activity that is carried out, as a rule, by health care profes-
sionals with training in pharmacotherapy and under their responsibility. Licensed health 
care professionals with appropriate training bear the overall responsibility for the provision 
of pharmacotherapy, and every employee giving pharmacotherapy or taking part in it is 
responsible for his/her actions. Foremen guide and supervise the carrying out of pharma-
cotherapy in accordance with a pharmacotherapy plan, as well as decide on the division 
of labour and co-operation between the different personnel groups so that the skills and 
knowledge of all groups are made use of optimally. 
The responsibility for the organisation of the drawing up, carrying out and monitoring of a phar-
macotherapy plan is vested in the management of the social and health care units. A well organised 
and managed pharmacotherapy also brings about savings in terms of expenses. The guidelines em-
phasise the need for developing attitudes and the operational culture through learning from errors 
and adjusting operational practices based on assessments. 
Key words: guidelines, health care, pharmacotherapy, safety
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TIIVISTELMÄ
Turvallinen lääkehoito. Valtakunnallinen opas lääkehoidon toteuttamisesta sosiaali- ja
terveydenhuollossa.
Sosiaali- ja terveysministeriön asettama työryhmä laati valtakunnallisen oppaan lääkehoidon to-
teuttamisesta julkisissa ja yksityisissä sosiaali- ja terveydenhuollon toimintayksiköissä. Turvallinen 
lääkehoito -oppaan tarkoituksena on yhtenäistää lääkehoidon toteuttamisen periaatteet, selkeyttää 
lääkehoidon toteuttamiseen liittyvä vastuunjako ja määrittää vähimmäisvaatimukset, joiden tulee 
toteutua kaikissa lääkehoitoa toteutettavissa yksiköissä. Oppaassa on myös esimerkkejä lääkehoi-
don toteuttamisen hyvistä käytännöistä. Oppaan laatimisen taustalla olevat kehittämistarpeet liit-
tyvät ennen muita lääkehoidon vastuukysymysten määrittämiseen eri toimialoilla, lupakäytäntöjen 
yhtenäistämiseen, työntekijöiden perehdyttämiseen sekä lääkehoidon osaamisen varmistamiseen ja 
ylläpitämiseen.
Lääkehoitoa ja verensiirtoja koskevat yleiset ohjeet ja periaatteet ovat samat kaikille terveyden- ja 
sosiaalihuollon julkisille ja yksityisille toimintayksiköille sekä lääkehoitoa toteutettaville muille alue-
ille. Oppaan mukaan lääkehoidon toteuttaminen perustuu toiminta- ja / tai työyksikössä laadittuun 
lääkehoitosuunnitelmaan, joka on työväline seuraavien lääkehoidon osa-alueiden määrittämiseen ja 
hallintaan:
Lääkehoidon sisältö ja toimintatavat• 
Lääkehoidon osaamisen varmistaminen ja ylläpitäminen• 
Henkilöstön vastuut, velvollisuudet ja työnjako• 
Lupakäytännöt• 
Lääkehuolto: lääkkeiden tilaaminen, säilytys, valmistaminen, käyttökuntoon saattamin-• 
en, palauttaminen, lääkeinformaatio, ohjaus ja neuvonta
Lääkkeiden jakaminen ja antaminen• 
Potilaiden informointi ja neuvonta• 
Lääkehoidon vaikuttavuuden arviointi• 
Dokumentointi ja tiedonkulku• 
Seuranta- ja palautejärjestelmät• 
Lääkehoito on terveydenhuollon toimintaa, jota toteutetaan pääsääntöisesti lääkehoidon koulu-
tuksen saaneiden terveydenhuollon ammattihenkilöiden toimesta ja vastuulla. Lääkehoidon koulu-
tuksen saaneet laillistetut terveydenhuollon ammattihenkilöt kantavat kokonaisvastuun lääkehoi-
don toteuttamisesta, ja jokainen lääkehoitoa toteuttava tai siihen osallistuva kantaa vastuun omasta 
toiminnastaan. Esimiehet ohjaavat ja valvovat lääkehoidon toteuttamista lääkehoitosuunnitelman 
mukaisesti sekä päättävät eri henkilöstöryhmien työnjaosta ja yhteistyöstä siten, että jokaisen am-
mattiryhmän osaaminen hyödynnetään parhaalla mahdollisella tavalla.
Vastuu lääkehoitosuunnitelman laatimisen, toteuttamisen ja seurannan organisoinnista on sosiaa-
li- tai terveydenhuollon toimintayksikön johdolla. Hyvin organisoitu ja hallitusti toteutettu lääke-
hoito tuo myös kustannussäästöjä. Oppaassa korostetaan asenteiden ja toimintakulttuurin kehit-
tämistä siten, että virheistä opitaan ja toimintatapoja muutetaan arvioinnin perusteella.
Asiasanat: lääkehoito, ohjeet, terveydenhuolto, turvallisuus
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REFERAT
Säker läkemedelsbehandling. Nationell handbok för genomförande av läkemedelsbehandling inom 
social- och hälsovården. 
En arbetsgrupp tillsatt av social- och hälsovårdsministeriet har utarbetat en nationell 
anvisning för genomförande av läkemedelsbehandling vid offentliga och privata social- och 
hälsovårdens verksamhetsenheter. Avsikten med Säker läkemedelsbehandling –handboken är att 
harmonisera principerna för läkemedelsbehandling samt tydliggöra ansvarsfördelning i fråga om 
läkemedelsbehandling och deﬁ niera de minimikrav som skall uppfyllas i alla enheter som genomför 
läkemedelsbehandling. Anvisningen har även exempel på goda praxis för läkemedelsbehandling. 
De utvecklingsbehov som ligger på bakgrunden till utarbetandet av anvisningen gäller först och 
främst deﬁ niering av ansvarsfrågor angående läkemedelsbehandling på olika verksamhetsgrenar, 
harmonisering av tillståndsförfaranden, utbildning av personalen och tryggande och upprätthållande 
av kunnande inom läkemedelsbehandling.
Allmänna anvisningar och principer angående läkemedelsbehandling och blodtransfusioner är de 
samma för alla offentliga och privata verksamhetsenheter inom social- och hälsovården samt övriga 
områden där läkemedelsbehandling genomförs. Enligt anvisningen skall läkemedelsbehandling 
bygga på en plan för läkemedelsbehandling som upprättats vid verksamhets- och/eller arbetsenheten 
och som är ett verktyg för deﬁ nition och administration av de följande delområden inom 
läkemedelsbehandlingen:
Innehåll i och förfaringssätt för läkemedelsbehandling• 
Tryggande och upprätthållande av kunnande inom läkemedelsbehandling• 
Personalens ansvar och skyldigheter samt arbetsfördelningen• 
Tillståndspraxis• 
Läkemedelsförsörjning: beställning, förvaring, tillverkning, framställning till användbart • 
skick och återlämning av läkemedel, läkemedelsinformation, handledning och rådgivning
Distribuering och tilldelande av läkemedel• 
Information och rådgivning till patienter• 
Bedömning av läkemedelsbehandlingens effekter• 
Dokumentering och informationsspridning• 
Uppföljnings- och responssystem• 
Läkemedelsbehandling är verksamhet inom hälso- och sjukvården som genomförs huvudsakligen 
av yrkesutbildade personer inom hälso- och sjukvården som utbildats inom och som har ansvaret 
för läkemedelsbehandlingen. Legitimerade yrkesutbildade personer inom hälso- och sjukvården 
som har utbildning inom läkemedelsbehandling bär totalansvaret för läkemedelsbehandling, och 
var och en person som genomför eller deltar i genomförande av läkemedelsbehandling bär ansvaret 
för sin egen insats. Cheferna styr och övervakar att läkemedelsbehandling genomförs enligt planen 
för läkemedelsbehandling samt bestämmer om arbetsfördelningen och samarbetet mellan olika 
personalgrupper så att kunnandet av var och en yrkesgrupp utnyttjas på det bäst möjliga sättet.
Ledningen för en verksamhetsenhet inom social- och hälsovården ansvarar för organisering 
av planeringen, genomförandet och uppföljningen av läkemedelsbehandlingsplanen.
Läkemedelsbehandling som är väl organiserad och som genomförs på ett samlat sätt  medför 
också kostandsbesparingar. Anvisningen poängterar att attityder och verksamhetskulturer 
skall utvecklas så att man lär sig av sina misstag och praxis ändras på basis av utvärdering.
Nyckelord: anvisningar, hälso- och sjukvården, läkemedelsbehandling, säkerhet
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1 INTRODUCTION
The social and health and social care sector is facing rising levels of risk. Improved 
process control procedures are thus necessary. As treatment practices develop, 
patient care is becoming more challenging and is increasingly being provided in 
non-healthcare settings. Due to population ageing, a growing proportion of care 
is also being provided in the home. In addition, changes to working practices and 
job roles mean that the work of medical and nursing staff is becoming increas-
ingly specialised. 
Drug therapies offer increasing potential for treatment and their use is on the 
rise due to the availability of more effective products and new formulations and 
administration routes. At the same time, adverse effects are also coming under 
increasing scrutiny. Finnish and international studies suggest that approximately 
10 per cent of patients will experience an adverse event during their treatment. 
Of these, a signiﬁ cant proportion is pharmacotherapy-related. In approximately 
1 per cent of cases the effects are severe (Weingart et al 2000, Davis et al 2003, 
Mustajoki 2005). The European Union (European Commission 2005), the Coun-
cil of Europe and the World Health Organisation are working together to reduce 
the incidence of medical errors and to improve patient safety. 
In healthcare operating units, drug therapies are ordinarily administered by 
healthcare professionals. Health supervisory authorities in Finland have identi-
ﬁ ed gaps in the knowledge and skills of medical and nursing staff involved in the 
administration of pharmacotherapy. Research has also pointed to shortcomings in 
the pharmacotherapy skills of graduate public health nurses and practical social 
and health and social care nurses (Huhtala 1996, Grandell-Niemi 1997, Murtola 
1999, Veräjänkorva 2003). In addition, myriad certiﬁ cation procedures and insuf-
ﬁ cient levels of guidance have been identiﬁ ed at healthcare unit level (Mattila & 
Isola 2002). 
Emergency care staff must have a strong pharmacotherapy skills and knowl-
edge base. Drug-related medical errors in emergency care may prove fatal due to 
the potency of many of the medications used. Emergency care pharmacotherapy 
practices and staff qualiﬁ cations and skills vary greatly.
In addition to healthcare operational units, pharmacotherapy is also adminis-
tered in social care units and other sectors, such as education and youth work. 
Pharmacotherapy practices within the social care sector also vary greatly and not 
all staff have been trained in pharmacotherapy as part of their basic training. It is 
often unclear who is entitled to administer medicines and what minimum quali-
ﬁ cations and skills are required. At times, drug therapies are administered by staff 
not trained in medication. 
Seamless co-operation between health and social care workers, pharmacies and 
the patient and/ or their representative or next of kin is particularly important 
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when care is being delivered at the patient’s home. In order for drug therapies 
to be successful, staff must ensure that information and guidance is offered to 
the patient and that the effects of the treatment are carefully monitored and re-
viewed. A study into home care arrangements found drug handling and distribu-
tion certiﬁ cation practices to be lacking in clarity and consistency and identiﬁ ed 
a failure on the part of service providers to carry out regular medical error and 
skills audits. Further training arrangements too were identiﬁ ed as requiring devel-
opment. Furthermore, the study suggested that co-operation with the next of kin 
and family is limited and little is being done to encourage them or the patient to 
participate actively in the pharmacotherapy process (Pietikäinen 2004). 
There is a need to clarify lines of responsibility, to harmonise certiﬁ cation 
practices and staff induction processes, to verify and maintain pharmacotherapy 
knowledge and skills and to address education and training issues (Mattila & Iso-
la 2002). Many health and social care operational units lack consistent protocols 
to govern the participation of students and staff with vocational qualiﬁ cations, 
Bachelor or Masters degrees in healthcare and social services in pharmacotherapy 
provision. 
The issuing of a prescription is the ﬁ rst step towards safe and high-quality 
pharmacotherapy. The prescription of medicines in Finland is regulated by the 
Ministry of Health and Social Affairs (Decree 726/2003). This guidance deals 
with prescriptions only insofar as they relate to the provision of pharmacothera-
py, addressing issues such as prescription errors, clarity and documentation. Par-
ticular attention is given to communication strategies and guidance offered to pa-
tients at the time of prescription and administration.
The guidance stops short, however, of issuing detailed instructions for the ad-
ministration of pharmacotherapy. It lays out general principles for the provision 
of safe and high-quality pharmacotherapy and discusses the specialist require-
ments placed on the care provided in social and health and social care operational 
units, emergency care units and service environments where pharmacotherapy is 
not routinely carried out. 
The guide applies to all health and social care units and environments where 
pharmacotherapy is provided, including health and social care operational units 
and service environments where pharmacotherapy is not routinely carried out, as 
well as outsourced and private health and social care service providers. This guide 
requires all units to prepare a pharmacotherapy plan, which will serve as a prac-
tical pharmacotherapy planning and management tool. It highlights the role and 
responsibilities of management in the planning, organisation and quality-assur-
ance of pharmacotherapy provision. The same pharmacotherapy principles and 
practices will apply across the board in all units but can be adapted according to 
local circumstances at unit level.
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2 KEY CONCEPTS
Concepts central to this guide are set out in Table 1 below. 
Tab 1. Key concepts
Activity subject to 
notiﬁ cation
Private sector service providers providing services other than 24-hour private 
social welfare services must provide advance notiﬁ cation in writing to the 
relevant local authority of the commencement, substantial alteration to or 
discontinuation of such a service. Notiﬁ cation is also required in the event 
of change to the person responsible for service provision. Local authorities 
must notify the relevant State Provincial Ofﬁ ce of such service provision for 
registration purposes.
Injections Intradermal, sub-cutaneous or intra-muscular injections and the techniques and 
procedures (including dosage and asepsis) required for their administration. 
Non-prescription medicines Medicines sold over the counter at pharmacies.
Domiciliary care Care and services enabling the patient to live primarily in their own home 
(home care services and related support services, home nursing services, 
preventative health and social care services, other support services) 
Non-parenteral medications Medications that can be administered without a separate procedure i.e. orally, 
rectally or as tablets, capsules, drops (including eye drops), ointments, patches, 
suppositories, inhalers etc.
Medicine A preparation or substance applied internally or externally for the purpose of 
treating, alleviating or preventing a medical condition or its symptoms. The 
term can also be extended to include internally or externally administered 
substances or combinations of substances used for the purpose of restoring, 
improving or changing physiological function through pharmacological, 
immunological or metabolic processes or for the purpose investigating the 
patient’s condition or cause of illness. 
Medication error Any pharmacotherapy-related and preventable adverse event, including 
medication errors, accidents and near misses. 
Licensed healthcare 
professionals trained in 
pharmacotherapy
Healthcare professionals whose basic training entails pharmacotherapy 
training and who have been authorised or licensed for practice by the 
National Authority for Medicolegal Affairs and are legally entitled to use the 
occupational title of licensed health and social care professional. 
Professionals with protected 
occupational titles trained 
in pharmacotherapy
Healthcare professionals with protected occupational titles whose basic 
training entails pharmcotherapy training, and who are entitled to use a 
protected occupational title.
Social care professionals 
trained in pharmacotherapy
Social, social and healthcare and pedagogical qualiﬁ cations incorporating 
training in pharmacotherapy.
Non-pharmacotherapy 
trained staff
Staff participating in the administration of pharmacotherapy excluding 
healthcare professionals trained in pharmacotherapy and social care 
professionals trained in pharmacotherapy. This includes healthcare 
professionals without training in pharmacotherapy, social care professionals 
without training in pharmacotherapy and other professionals such as teachers 
and special needs assistants. Also included are the next of kin/ family and 
personal assistants. 
Service environments where 
pharmacotherapy is not 
routinely carried out
Environments where pharmacotherapy is not carried out as a typical or core 
activity, including social welfare services such as nursery services, educations 
service and services for young people. In these service environments, 
pharmacotherapy is commonly carried out by persons without training and 
under a joint agreement between the patient/ client and the relevant member 
of staff. 
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Pharmaceutical services The procurement, preparation, storage and supply of medicines and 
the provision of pharmaceutical information and guidance to social and 
healthcare operational units, including wards, out-patient clinics and patients. 
Pharmaceutical services units include community pharmacies, hospital 
pharmacies, medicine centres and pharmaceutical wholesalers. 
Formulary A list of medicines set and authorised by specialists at the unit. Primarily made 
up of regularly used medicines but also contains some less frequently used but 
necessary medicines. The formulary is designed to standardise and guide the 
purchase and use of medicines at the unit. The formulary will be kept under 
review. 
CNS agents Agents acting on the central nervous system include pharmaceutical products
- included in the National Agency of Medicines list of CNS agents
- preﬁ xed with the letters Z, ZA, P and PA in the National Agency of Medicines 
list of agents and which can only be dispensed against a prescription
- deﬁ ned as CNS agents under the terms of the marketing authorisation.
Patient/ client Throughout this guide the term patient is used to denote persons receiving 
pharmacotherapy. Pharmacotherapy is a healthcare activity and both the 
activity and the status of the patient are subject to healthcare legislation 
irrespective of whether the patient is receiving health and social care. 
Prescription medicine Medicines that can only be dispensed against a prescription issued by a doctor, 
a dentist or a veterinarian.
Social care professionals Qualiﬁ cation requirements for social care work, where skills acquired as part of 
a degree in social welfare, social and healthcare and education are necessary for 
the professional discharging of duties.
Social care unit Retirement homes, sheltered housing, substance abuse units, nurseries, child 
protection units, institutional care for the disabled, domiciliary and units 
providing private social care services, including sheltered housing for mental 
health patients, sheltered housing and domiciliary and foster care. Also private 
units providing 24-hour social care services subject to licensing (Act on the 
supervison of private social care services, 603/1996, available in Finnish and 
Swedish only)
Social care work unit Individual work units within a social care unit.
Intravenous treatment Intravenously provided ﬂ uid, medicine, including titration and preparation. 
Also denotes procedures required in the provision of intravenous therapies, such 
as peripheral arterial cannulation 
Healthcare professionals Licensed healthcare professionals, authorised healthcare professionals and 
healthcare professionals with protected occupation titles as deﬁ ned in the Act 
on Healthcare Professionals (559/1994).
Healthcare unit As deﬁ ned in the Act on the Status and Rights of Patients (785/1992), including 
primary healthcare units, units providing specialist healthcare services and 
private healthcare services (units under license for private healthcare provision). 
Healthcare work units Individual work units operating under larger healthcare units, including 
domiciliary care, emergency and ambulance services and outpatient clinics and 
departments.
Narcotics Pharmaceutical products containing substances listed in Schedules I, II and IV 
of the Single Convention on Narcotic Drugs and Schedules I and II of the Single 
Convention on Psychotropic Substances (including morphine, methadone, 
fentanyl, sufentanil and pethidine).
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3 PHARMACOTHERAPY – CURRENT 
OVERVIEW AND CHALLENGES
There is currently signiﬁ cant variation in Finnish pharmacotherapy practices and 
insufﬁ cient action is being taken by social and health and social care units to 
develop service provision and to ensure that the appropriate staff skills are in 
place. Changes to the healthcare operational environment, diverse staff educa-
tional backgrounds and skills levels, increasing drug potency and medication er-
rors mean that changes to pharmacotherapy practices are warranted. Operational 
unit supervisory practices are to be enhanced to ensure that pharmacotherapy 
practices, task allocation and the role of healthcare managers can be clariﬁ ed. 
There is also scope for better use to be made of the feedback received through 
medical injury reports, disciplinary processes, complaints and supervisory author-
ity rulings. 
Problems in pharmacotherapy and medication errors are being brought un-
der increasing scrutiny. The no-blame learning culture currently being promoted 
means that healthcare professionals can feel more comfortable coming forward 
to report medication errors. However, due to the lack of systematically gathered 
data, it is difﬁ cult to estimate whether the incidence of medication errors has in-
creased in recent years or whether they are more in evidence due to staff being 
more willing to report them. 
Skills gaps are most commonly found in the following areas: awareness of rel-
evant legislation and guidance, drug calculations, knowledge of proportions and 
dosages and understanding of drug effects (Huhtala 1996, Grandell-Niemi 1997, 
Murtola 1999, Veräjänkorva 2003). The aims and objectives for pharmacotherapy 
teaching and core content are set out in the nursing (polytechnic) skills matrix-
es and in the national core curriculum for the upper secondary vocation nursing 
qualiﬁ cation and stand-alone qualiﬁ cation requirements (The Finnish National 
Board of Education 2001, Ministry of Education 2001). Although polytechnics in 
Finland are entitled to set out their own curricula, they must adhere to skills ma-
trixes issued by the Ministry of Education. The institutions must also follow the 
practical nursing degree curriculum and competence-based qualiﬁ cation require-
ments, as set out by the National Board of Education. 
Under the skills matrixes, nurses (polytechnic qualiﬁ cation), emergency medi-
cal technician/ paramedics (polytechnic qualiﬁ cation) and midwives (polytech-
nic qualiﬁ cation) must be provided with extensive training in different types of 
drug therapies. Graduate nurses must be able to carry out pharmacotherapy using 
different administration routes, intravenous ﬂ uid and drug therapies, in accord-
ance with written instructions from manufacturer and supplier (hospital pharma-
cy). Nurses must be able to monitor the patient’s condition and symptoms and 
17
Safe Pharmacotherapy
National Guide for Pharmacotherapy in Social and Health Care
assess drug therapy efﬁ cacy both during and after treatment. In addition, nurses 
must be able to carry out drug calculations and undertake key pharmacotherapy 
procedures, including injections. Further key areas include patient education and 
self-care promotion. (Ministry of Education 2001).
The curriculum requires that the basic vocational qualiﬁ cation in social and 
health and social care (practical nursing qualiﬁ cation) must equip graduates with 
the skills to administer pharmacotherapy in accordance with instructions re-
ceived using different administration routes, including intra-muscular and sub-
cutaneous injections and to dispense medications to patients using a tray-system. 
Graduate practical nurses must be able to monitor and report on drug therapy 
efﬁ cacy, interactions and side effects and provide guidance and counselling to pa-
tients. In addition, practical nurses must be able to monitor the patient’s condi-
tion and symptoms and assess drug therapy efﬁ cacy both during and after treat-
ment. (National Board of Education 2001). 
Pharmacotherapy teaching offered in polytechnics and vocational colleges con-
tinues to vary greatly, however, and the above skills requirements and aims are 
not always met in the curricula set by the individual institutions. A further issue 
is the absence of quantitative targets or minimum credit thresholds from the na-
tional curriculum requirements. Divergent pharmacotherapy teaching practices 
are leading to variation in graduate knowledge and skills levels. 
The way in which pharmacotherapy skills are acquired in the work place also 
varies. The current core curriculum and skills matrixes fail to specify a target for 
participation in the administration of drug therapies during on-the-job learning 
and supervised training and the number of credits available for such placements. 
There is also variation in the level of resourcing and time allocated to guidance 
and the skills and attitudes of the supervisors involved. The continuing profes-
sional education offered to supervisors and teachers must also be improved. Stud-
ies have shown that teachers tend to focus on their own areas of expertise at the 
expense of areas that are signiﬁ cant for the students’ professional development 
(Veräjänkorva & Leino-Kilpi 1998). 
The differences in training are leading to signiﬁ cant variation in new graduates’ 
pharmacotherapy skills and knowledge. It is the employer’s responsibility to as-
sess to what extent the employee is able to participate in the administration of 
drug therapies, as this too can vary considerably. In particular, clariﬁ cation is re-
quired on the participation of students and professionals with protected occupa-
tions titles in the provision of pharmacotherapy and related lines of responsibil-
ity. As drug therapies are also widely administered in environments where this 
constitutes a non-routine part of the service, including social welfare operational 
units, guidance is required on the participation of non-healthcare staff in phar-
macotherapy provision. 
Pharmcotherapy practices currently vary widely among social welfare and 
healthcare operational units. A report on Finnish hospital districts examined the 
process used to certify nurses in pharmacotherapy provision (Mattila & Isola 
2002). It identiﬁ ed signiﬁ cant variation between hospital districts and units, with 
some units found to employ a multi-stage, systematic certiﬁ cation processes and 
others having no written process in place. Disparate certiﬁ cation models were al-
so found.
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Under a previous National Board of Health circular (1929/1987), doctors 
were responsible for the granting of certiﬁ cates in hospitals and health centres, 
with nurses mainly in charge of pharmacotherapy provision, supported by other 
healthcare professionals with the required training and skills. Following the re-
view of the Medicines Act and the abrogation of the National Board of Health 
circular, no guidance has been issued. It should be noted, however, that practice 
in this regard has continued to follow the principles laid down in the circular. In 
the event that tasks are delegated to another healthcare professional, the employ-
er must provide the necessary training, ensure that the employee in question has 
the skills required for the allocated tasks and provide a unit-speciﬁ c certiﬁ cate or 
work order.
Hospital and health centre pharmaceutical staff are mainly based in hospital 
pharmacies and medicine centres. In broad deﬁ nition, ward pharmacy, is the pro-
vision of a full range of pharmaceutical services to a ward or a clinic. The devel-
opment of ward pharmacy services in Finland began in the 1980s. Pharmacists 
were initially brought in to oncology wards to prepare chemotherapy dilutions 
and other medicines but their involvement soon extended to other areas, includ-
ing the provision of pharmaceutical advice, the preparation and distribution of 
medicines, the ordering of medicines from the pharmacy and the management 
of ward medical stocks. This was intended to ease nursing workloads. Since 2000, 
pharmacists’ involvement has again increased to comprise pharmaceutical advice, 
the provision of pharmacology training to nurses and quality control (Lehtomäki 
et al 2005).
Until now, there have been no guidelines on the provision of pharmacotherapy 
in emergency care. Shortcomings have also been identiﬁ ed in monitoring prac-
tices. As a result, it has not been clear where overall responsibility for the ad-
ministration of pharmacotherapy has rested. Pharmacotherapy procedures have 
also been inconsistent. The level and extent of training received by emergency 
care staff also varies signiﬁ cantly by profession. The different professions involved 
in the provision of emergency care services include ﬁ re ofﬁ cer - ambulance at-
tendants, hospital and ambulance attendants, rescue staff, practical nurses, nurses, 
emergency care nurses (polytechnic qualiﬁ cation) and doctors, including emer-
gency care specialists. 
In emergency care, pharmacotherapy is commonly administered under little 
supervision. Emergency care staff must be able to carry out initial patient assess-
ments to allow the commencement of appropriate treatment. The range of medi-
cations used includes many highly potent, intensive care drugs whose side effects 
must be managed swiftly and without a doctor being present. The majority of in-
cidents requiring emergency care take place outside of health centres and hospi-
tals. Patient transport staff are generally given additional pharmacotherapy train-
ing. All hospital districts and health centres now employ doctors with particular 
operational responsibility for emergency care and patient transport, which has re-
sulted in improvements in this area. There remains scope for enhanced co-oper-
ation between primary and secondary health and social care services to improve 
emergency care practices and guidelines, however. 
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In the social welfare sector and service environments where pharmacotherapy 
is not routinely carried out, it is administered in a variety of environments and by 
staff with varying levels of qualiﬁ cation and training. In the social welfare sector, 
pharmacotherapy is administered in retirement homes, care homes for children 
and the disabled, different types of sheltered accommodation for the elderly, the 
disabled, substance abuse and psychiatric patients, in different types of kindergar-
tens and nurseries, foster care and in the clients’ own homes. In addition, pharma-
cotherapy can be administered in schools and at after-school clubs. 
Current social welfare legislation does not cover staff participation in pharma-
cotherapy. Guidance and supervision arrangements and lines of responsibility al-
so often remain unclear. In many instances, service providers have failed to take a 
proactive approach to the management of pharmacotherapy provision, planning 
has been insufﬁ cient and patient safety structures have not been ﬁ t for purpose. 
There is signiﬁ cant variation in staff training and competence levels and it is often 
unclear what qualiﬁ cations or training are required for participation in pharma-
cotherapy provision. Further training practices also vary. 
In sectors where pharmacotherapy is not typically provided, administration is 
often carried out by untrained staff. This occurs most commonly in the day care 
or school setting, where staff administer medications supplied by the guardian. 
In these instances, the guardian is responsible for delivering the medication and 
ensuring that sufﬁ cient instructions are provided. The relevant member of staff is 
responsible for administration. Particular challenges in this scenario include the 
deﬁ nition of lines of responsibility and accountability as well as staff skills veri-
ﬁ cation. 
Due to polypharmacy, the most challenging pharmacotherapy is often admin-
istered by the elderly in the home setting. Drug incompatibilities may result in 
severe side effects, unnecessary suffering and increased public cost. Several in-
ternational studies have shown polypharmacy and drug incompatibilities to be 
common among the elderly. Furthermore, it has been found that polypharmacy 
and the number of doctors involved in the treatment of any one patient increase 
the risk of drug interactions (Barat et al 2000, Halkin et al 2001, Björkman et al 
2002, Socialstyrelsen 2004.) In Finland, too, polypharmacy and drug incompat-
ibilities, inadequate pharmacotherapy monitoring and assessment (Linjakumpu 
et al 2002) and communications strategies (Kansanaho et al 2002) are coming 
under the spotlight. 
Automated drug distribution systems support rational and cost-efﬁ cient phar-
macotherapy provision and allow staff to dedicate more time to patient care. 
These systems are particularly useful in units where not enough staff are trained 
in pharmacotherapy. Further beneﬁ ts include the full medication review of each 
patient that is carried out prior to the commencement of the automated service. 
The review is designed to eliminate any unnecessary medications, drug overlaps 
and harmful interactions and can be carried out by the pharmacy in co-operation 
with the doctor and, where relevant, other healthcare professionals. The process 
also brings cost savings. Studies suggest that savings are generated through re-
duced drug wastage and staff workloads (Larsson & Block 1998, Riksförsäkrings-
verket 2001, Econ Senter For Okonomisk Analyse As 2002, Saikkonen 2003). 
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Considerable additional beneﬁ ts are achieved through medication reviews and 
reduced numbers of medication errors. 
There is currently no systematic process for gathering data on medication er-
rors, including near misses, in Finland. Danish legislation, for example, requires 
systematic monitoring of all medication errors. No such requirement or system 
exists in Finland. International studies have found that approximately 10% of all 
patients experience an adverse event during their treatment. Of these a signiﬁ -
cant proportion are related to drug treatments (Institute of Medicine 2000) and 
the majority are preventable (Hughes & Ortiz 2005). 
The Peijas Hospital Viisas oppii virheistä (“To err is to learn”)(VIIVI) project 
was set up to record daily medical errors with the view to developing process-
es for reducing treatment errors (HUS 2004, Mustajoki 2005). The results show 
that the most common errors were prescription, documentation, distribution and 
administration-related. In the majority of cases the errors did not warrant further 
treatment. The VIIVI ﬁ ndings are in line with international studies, which sug-
gest that the majority of adverse events are non-serious and only one per cent go 
on to cause severe harm (Institute of Medicine 2000, Weingart et al 200, Davis 
et al. 2003). 
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4 THE PHARMACOTHERAPY PROCESS
Pharmacotherapy is a key form of medical intervention and an important compo-
nent of patient care as a whole. It is always a form of health and medical care, re-
gardless of where it is being administered. At its best, pharmacotherapy is multi-
disciplinary work across unit and organisational boundaries, between the patient, 
the doctor and the administering staff. Pharmacy staff and advice and counselling 
services have an increasing role to play in both pharmacies and social and health-
care settings. 
The commencement, adjustment and discontinuation of drug therapies is initi-
ated by the doctor in consultation with the patient. Successful pharmacotherapy 
is dependent upon correct prescription practice (Finnish Pharmacists’ Associa-
tion & Union of Health and Social Care Professionals Tehy ry 2003). The doc-
tor undertakes an assessment of the patient’s drug therapy needs taking into ac-
count the patient’s health status, illnesses, earlier medications and allergies. This 
is then used to draw up an individual drug treatment plan. In future, electronic 
support software combining information from relevant clinical guidelines and the 
patient’s own records will be used to assist in the selection of medication. Drug 
treatments are commenced when indicated by the patient’s individual needs and 
their continuation is subject to a positive response. The treating doctor must for 
their part ensure that the information provided to the patient meets the require-
ments set out in the Act on the Status and Rights of Patients and the Decree on 
Prescriptions. 
Prescriptions are to be issued on the basis of need as established by investiga-
tion or other clinical method. Provided that the appropriate training has been 
made available, nurses and public health nurses can be delegated/ authorised 
to participate in the assessment of the patient’s needs (Hukkanen & Vallimies-
Patomäki 2005). Issues to consider when issuing a prescription are indication, ef-
ﬁ cacy, safety and cost. Prescriptions must be clear and unambiguous and contain 
all information required for safe administration. 
Diagnostic errors include misdiagnosis and delay. Errors in the assessment of 
treatment need result from failure to take into account medication allergies, poly-
pharmacy, contraindications and drug interactions. Medication errors include the 
wrong active ingredient (non-proprietary name, INN) or preparation, pharma-
ceutical form, dosage strength or concentration, route of administration and treat-
ment duration. Erroneous or unclear prescriptions can lead to misunderstandings 
and treatment errors. Guidance errors include the provision of inadequate or 
contradictory information. Figure 1 sets out the risks associated with pharmaco-
therapy from the point of view of the doctor. (Centre for Pharmacotherapy De-
velopment ROHTO.)
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Fig 1. Pharmacotherapy risks – the doctor’s perspective
Pharmacotherapy is administered as prescribed by the doctor. Those adminis-
tering drug treatments must make sure that they have understood the prescrip-
tion correctly, prepared the medicines in accordance with the instructions pro-
vided and ensure that the correct medications are administered in the correct 
dosage and formulation, at the right time, via the correct administration route. 
Medicines that are not ready for use will be prepared by staff with pharmaco-
therapy training in a controlled environment such as a hospital pharmacy. The 
preparation process must be fully documented. Where medications are prepared 
for use at a ward or at home, all relevant regulations and guidelines (e.g. Nation-
al Agency of Medicines Decree 5/2002, available in Finnish and Swedish only) 
must be observed.
Skilled and knowledgeable staff are a pre-requisite for high-quality pharmaco-
therapy provision. Where necessary, staff without training in pharmacotherapy in 
their basic qualiﬁ cation may assist healthcare professionals and social care pro-
fessionals with pharmacotherapy training in the provision of pharmacotherapy. 
However, it must be ensured that those providing pharmacotherapy have written 
permission to do so and have obtained the required knowledge and skills through 
training. 
Efﬁ cacy assessment is a key part of pharmacotherapy provision. In in-patient 
care, staff involved in the provision of pharmacotherapy monitor the patient’s 
condition and observe any potential side effects. In ambulatory care, the patient’s 
self-management skills and knowledge of potential adverse effects are particular-
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ly important. Also important are good working relationships between care staff 
and staff involved in the provision of drug treatment. Staff administering the 
treatment assess treatment efﬁ cacy in co-operation with the doctor and patient. 
Administration and efﬁ cacy must be appropriately documented. A positive re-
sponse is a pre-requisite for treatment continuation. In the event of side effects 
or insufﬁ cient treatment response, the doctor will decide on whether treatment 
is to be continued and/ or adjusted.
Errors in the receipt of prescriptions may result from the prescription con-
tent being misunderstood or the prescription being incorrectly transcribed/ docu-
mented in the patient records. Such errors can occur during prescription transfer 
or when the prescription is copied onto the so-called prescription chart or com-
municated orally. Errors related to patient identity, medication type, preparation 
and strength or concentration can occur when medicines are administered. Prep-
aration errors can occur during dosing, division and crushing of medicines. Ad-
ministration errors include incorrect time of administration, incorrect administra-
tion routes and methods, strength and dosage. The medication may also be missed 
or given to the wrong patient. Guidance-related errors are the same as for doc-
tors. Errors in assessing treatment efﬁ cacy can lead to insufﬁ cient information be-
ing communicated to the doctor. Figure 2 sets out the risks associated with phar-
macotherapy from the point of view of administering staff. Figure 3 sets out the 
risks associated with pharmacotherapy from the point of view of domiciliary care, 
nursing home and sheltered accommodation staff. (Centre for Pharmacotherapy 
Development ROHTO.)
Fig 2. Pharmacotherapy risks – administering staff perspective
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Fig 3. Pharmcotherapy risks – the domiciliary care, nursing home and sheltered 
accommodation perspective 
Community pharmacies, hospital pharmacies and medicine centres play a key 
role in safe pharmacotherapy provision. Communication errors may take place 
when medicine orders placed at the ward are received and processed at the phar-
macy. Preparation errors include deﬁ ciencies in ingredient quality and the phar-
maceutical and microbiological processes used. Delivery errors may be due to 
inappropriate storage or insufﬁ cient security arrangements allowing third party 
access to the medication. Documentation errors may result from insufﬁ cient in-
formation or inaccurate or unclear notes. Figure 4 sets out sets out the risks asso-
ciated with pharmacotherapy from the hospital pharmacy point of view. Figure 
5 sets out the risks associated with pharmacotherapy from the community phar-
macy point of view. (Centre for Pharmacotherapy Development ROHTO).
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Fig 4. Pharmacotherapy risks, hospital pharmacy perspective
Fig 5. Pharmacotherapy risks – community pharmacy perspective
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In ambulatory care, the patient’s general state of health and their knowledge 
and skills inﬂ uence their ability to self-manage their condition and thus the out-
come of their treatment. Where possible, the patient should be invited to par-
ticipate in the planning of their drug therapy and be aware of its aims and any 
monitoring and assessment taking place. The treating doctor and other staff must 
be available to offer guidance and counselling and respond to any questions the 
patient may have. The prescribing doctor must ensure that the patients or their 
next of kin have correctly understood dosage and administration instructions. 
Doctors’ obligations in this regard are set out in more detail in the Ministry of 
Social Affairs and Health Decree on prescriptions (726/2003, available in Finn-
ish and Swedish only). 
The indication for the prescription must be explained and instructions for use 
must be provided. The patient must also be made aware of potential adverse ef-
fects and when they should contact the treating doctor or other healthcare staff. 
The patient must also be informed of potential side effects, interactions with 
other medications or alcohol and drugs and the impact on their performance, in-
cluding driving ability. It is also advisable for the patient’s next of kin to be made 
aware of the drug’s effects. Guidance and counselling are central to successful and 
safe pharmacotherapy. The patient may refuse drug therapies recommended by 
the doctor and is entitled to receive appropriate alternative treatment. However, 
there is no obligation to deliver treatment demanded by the patient. 
Errors occurring during the taking of medications may result from the medi-
cation being taken at the wrong time, in the wrong preparation or in the wrong 
quantity, amount, volume etc. Guidance errors may be caused by shortcomings in 
the guidance content or the way in which it is received by the patient. Problems 
may also be caused by ill-informed self-medication practices, such as the use of 
over-the-counter medications the doctor is unaware of. Figure 6 sets out the risks 
associated with pharmacotherapy from the point of view of the patient. (Centre 
for Pharmacotherapy Development ROHTO).
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Fig 6. Pharmacotherapy risks – the patient’s perspective
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5 PHARMACOTHERAPY 
The same general principles and guidelines apply to the provision of pharmaco-
therapy services in all public and private social and health and social care units 
as well as environments where pharmacotherapy is not routinely carried out. 
Pharmacotherapy is to be provided in accordance with a health and social care 
unit-speciﬁ c or work unit-speciﬁ c plan detailing all pharmacotherapy. All health 
and social care and/or work units are required to have a pharmacotherapy plan 
in place. The pharmacotherapy plan is a key management and quality assurance 
tool. The exact content of the plan is determined by the unit’s activities and the 
type of pharmacotherapy provided. This reﬂ ects the fact that competency re-
quirements placed, for example, on the provision of pharmacotherapy in inten-
sive care units differ considerably from standard in-patient ward requirements. 
Competency requirements will be determined at operational unit level and 
should be used to guide the production of the work unit-level pharmacothera-
py plan. Units with similar functions are encouraged to cooperate in the draw-
ing up of the plan. Table 2 provides a break down of the pharmacotherapy plan 
content. 
Tab 2. The pharmacotherapy plan
Pharmacotherapy: content and processes• 
Verifying and maintaining pharmacotherapy knowledge and • 
skills 
Staff duties and responsibilities and task allocation• 
Certiﬁ cation practices• 
Pharmaceutical services: ordering, storing, manufacture, • 
preparation and return of medicines; provision of information, guidance and 
advice 
Distribution and administration of medicines • 
Informing and counselling patients• 
Efﬁ cacy assessments• 
Recordkeeping and information ﬂ ow• 
Feedback and monitoring systems• 
A pharmacotherapy plan should contain an analysis of the health and social 
care and/ or work unit pharmacotherapy activity and needs, a process descrip-
tion, a staff structure chart and job descriptions, a deﬁ nition of lines of respon-
sibility and a pharmacotherapy skills assessment together with a skills veriﬁ ca-
tion and maintenance plan. It should also include details of the staff certiﬁ cation 
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process. In addition, the plan must cover pharmaceutical services, record keeping 
practices, efﬁ cacy assessments as well as patient information and guidance prac-
tices. A feedback system is to be implemented for gathering data on medicine er-
rors, which can be used for monitoring and learning purposes. Every effort is to 
be made to promote a culture of openness and learning. 
Management teams are responsible for organising the preparation, implemen-
tation and monitoring of the pharmacotherapy plan. They will be supported by 
the medical director, nursing director, pharmacotherapy clinical lead or unit (e.g. 
hospital pharmacy or medicine centre) and nursing staff providing pharmaco-
therapy. Plans for social service providers and service environments where phar-
macotherapy is not routinely carried out will be drawn up in co-operation be-
tween the management team, the clinical lead and the nursing staff providing 
pharmacotherapy. The plan is to be reviewed annually and updated as necessary. 
Hospital districts co-ordinate the preparation of the pharmacotherapy plans re-
gionally. The preparation and implementation of the plan is supervised by the 
County Administrative Boards, who may request access to the plan in conjunc-
tion with a licence inspection or other supervisory visit. Table 3 sets out the proc-
ess from the guidance and supervisory authority, education and training provider 
and health and social care unit perspective.
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Tab 3.  The pharmacotherapy process – supervisory authority, education and training 
provider and health and social care unit perspective
Body Process
Ministry for Social Affairs 
and Health
Legislation
General supervisory, guidance and management duties
National Agency for 
Medicines
Supervision and guidance of pharmaceutical services and medicinal products 
and medical devices.
Ministry of Education 
Finnish National Board of 
Education
Ministry of Education: curriculum recommendations 
Finnish National Board of Education: curriculum orders
Polytechnics, vocational 
colleges
Curriculum planning and implementation 
Skills examinations for practical nurses from 1 August 2006
Hospital districts,
Health boards
Regional co-ordination of pharmacotherapy plan
Co-ordination of feedback system
Co-ordinating continuing professional education
Maintenance of continuing professional education and further training registers
Maintenance of pharmacotherapy certiﬁ cation register
Health and social care unit Co-ordination of pharmacotherapy plan preparation, implementation, 
monitoring and assessment
Deﬁ nition of competencies required at work unit level
Identifying units where pharmacotherapy plans prepared jointly/ independently
Certiﬁ cation principles and delegation of responsibility
Co-ordinating continuing professional education
Feedback utilisation
Work unit Pharmacotherapy plan preparation, implementation, monitoring and assessment
Feedback utilisation
Administering staff, 
consultants, 
senior nurses,
hospital pharmacy/ ward 
pharmacy
Pharmacotherapy plan implementation
Ensuring skills, workforce planning, training provision
Certiﬁ cation implementation
Social and health and 
social care professionals 
with pharmacotherapy 
training
Pharmacotherapy provision
Reporting of errors
Professional skills maintenance and development 
County Administrative 
Boards
Reporting 
Guidance and supervision of health and social care organisations and 
professionals
National Authority for 
Medicolegal Affairs
Reporting
Supervision and guidance of healthcare organisations and professionals
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5.1 Pharmacotherapy practices and procedures
Pharmacotherapy content, practices and procedures are set out in the pharma-
cotherapy plan. Comprehensive operational knowledge and analysis of related 
problem areas and risk factors is required for the effective management and de-
velopment of pharmacotherapy services at the operational and work unit levels. 
At the planning stage, cognisance should be taken of the fact that pharmacother-
apy provision is healthcare activity provided, as a rule, by and under the respon-
sibility of health and social care professionals trained in pharmacotherapy. The 
unit’s own pharmacotherapy competency requirements determine the scope of 
the pharmacotherapy plan. Table 4 sets out the pharmacotherapy content and 
procedures. 
Tab 4. Pharmacotherapy content and procedures
Determining unit pharmacotherapy competency • 
requirement
Determining unit pharmacotherapy practices• 
Determining problem areas and risk factors• 
Identiﬁ cation and development of pharmacotherapy key areas• 
Description of pharmacotherapy processes• 
Table 5 sets out the pharmacotherapy accountability framework and process 
from the patient and administering staff perspective.
Tab 5. Pharmacotherapy process, patient and administering staff perspective
Actor Process
Patient Pharmacotherapy need 
Doctor Assessing the need for pharmacotherapy, diagnosis, prescriptions, informing 
and counselling patients, planning follow-up treatment
Patient/ administering staff/ 
next of kin
Obtaining medication
Pharmaceutical staff Preparation, delivery, information
Patient/ administering staff/ 
next of kin
Preparation, administration, information, guidance, monitoring and assessment
Patient Treatment completed, indication for follow-up assessed
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5.2 Verifying and maintaining pharmacotherapy 
knowledge and skills 
Administering staff should be aware of the role of pharmacotherapy in the wider 
treatment context. They are also expected to understand the full treatment span 
including the prescription indication, the agent prescribed, dosage and admin-
istration route. They should also be able to assess treatment efﬁ cacy. Technical 
skills alone are not sufﬁ cient, however; the administration of pharmacotherapy 
also requires a sound understanding of ethico-legal issues, pharmacology, physi-
ology, pathophysiology and drug calculations. In addition, staff must have knowl-
edge of treatment effects, drug handling and delivery methods as well as drug ac-
quisition and disposal. An understanding of dosage forms, preparations and their 
properties is necessary to ensure that correct handling procedures are followed 
when preparing and administering medications. As an example, safe pharamco-
therapy requires that sterile preparations are protected from contamination and 
the slow-release properties of orally administered medications are not destroyed 
through crushing.
Each work unit must have in place an induction plan, setting out unit-speciﬁ c 
pharmacotherapy procedures, which each new, temporary or student employee 
must familiarise themselves with.  During the induction process, the unit super-
visor or other staff member in charge of induction must ensure that employees 
have the basic skills required for the provision of pharmacotherapy, obtained 
through basic training. Further guidelines on skills testing, tailored to reﬂ ect the 
type of drug therapies provided, will be made available at unit-level. The unit 
may require an employee to distribute medicines two to ﬁ ve times under the su-
pervision of the induction provider before they can be certiﬁ ed to undertake the 
task independently. At the end of the induction period, the head of the work unit 
will determine whether the employee has sufﬁ cient knowledge of the health and 
social care / work unit pharmacotherapy practices and whether the induction 
aims have been achieved. 
Health and social care / work units are required to produce an assessment of 
the skills and knowledge required for pharmacotherapy provision and to identi-
fy training needs. Staff skills and knowledge are to be maintained, developed and 
monitored in accordance with national legislation and guidance (Ministry of So-
cial Affairs and Health, 2004) The employer is required to provide training that 
meets staff and unit development needs. The employer is responsible for provid-
ing continuing professional education to health and social care staff with basic 
training in pharmacotherapy. The employer is also responsible for providing train-
ing to staff who are involved in the provision of pharmacotherapy but who have 
no basic training in this area. Staff involved in the provision of pharmacotherapy 
are required to maintain their skills and to participate in training provided by the 
employer. Training and electronic learning materials and environments are being 
developed through regional co-operation, coordinated by hospital districts.
Each health and social care unit has in place a continuing professional educa-
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tion register and other monitoring systems, which will be used to assess and re-
view skills and training needs and participation. Monitoring can also be carried 
out in regional or local cooperation, in which case hospital districts and health 
boards can use the register to store information on pharmacotherapy training 
provision, staff participation and cost and certiﬁ cation practices. The register can 
also be used for skills and training review tool and to facilitate the assessment of 
pharmacotherapy skills during the annual performance review process. Table 6 
sets out the information required for inclusion in the pharmacotherapy plan.
Tab 6. Pharmacotherapy skills requirements, verifying and maintaining pharmacotherapy 
knowledge and skills
Identifying knowledge and skills requirements • 
Assessing staff skills and training needs• 
Pharmacotherapy induction – written plan, unit-speciﬁ c instructions, verifying • 
skills and 
knowledge obtained through basic education
Verifying and maintaining skills and knowledge - testing, performance reviews, • 
assessing training efﬁ cacy
Skills maintenance and development – training participation in accordance with • 
continuing professional education plan
Continuing professional education register maintained by the hospital district or • 
health 
board
5.3 Staff accountability, duties and task allocation
The health and social care / work unit staff structure, duties and responsibilities 
are set out in the pharmacotherapy plan. The health and social care unit man-
agement board and health and social care/ medical director are responsible for 
pharmacotherapy planning and implementation in cooperation with the nursing 
director and the health and social care unit/ work unit pharmacotherapy clini-
cal lead. Line managers are responsible for ensuring that staff participating in 
pharmacotherapy provision are in possession of the necessary skills and knowl-
edge and able to carry out their duties in the appropriate conditions. Line man-
agers guide and monitor the provision of pharmacotherapy in accordance with 
the pharmacotherapy plan. They are also responsible for managing task allocation 
and co-operation between the different professions to ensure that optimal use is 
made of the skills and knowledge available.
Doctors manage the prescription of medicines and therefore have overall re-
sponsibility for pharmacotherapy provision. Healthcare professionals (as deﬁ ned 
in the Act on Heathcare Professionals) are responsible for the administration of 
drug therapies in accordance with the doctors’ instructions. Doctors assess treat-
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ment needs and efﬁ cacy, and provide information and advice in cooperation with 
healthcare professionals trained in pharmacotherapy. Doctors must take congni-
sance of the requirements the prescribed therapies place on the staff administer-
ing them. For example, this means taking account of the arrangements required 
for the night-time administration of intravenous treatments when no staff with 
pharmacotherapy training may be on duty.  
Licensed healthcare professionals with pharmacotherapy training have overall 
responsibility for pharmacotherapy provision at unit-level. Overall responsibil-
ity is deﬁ ned as responsibility for task allocation, the provision of related guid-
ance, supervision and counselling as well as service functionality. These tasks are 
included in the duties of ward managers and nursing directors. However, all staff 
involved in pharmacotherapy provision are responsible for their own actions. 
Intravenous ﬂ uid and drug therapies and patient controlled analgesia (PCA) 
can only be administered by licensed healthcare professionals trained in pharma-
cotherapy. Radiographers, for example, can participate in imaging investigations 
and procedures requiring intravenous medication. However, participation is sub-
ject to skills veriﬁ cation, additional training where applicable and certiﬁ cation by 
a doctor employed at the same health and social care unit. Temporary staff may 
participate in the administration of intravenous drug therapies if their skills and 
knowledge have been veriﬁ ed and they have undertaken further training on intra-
venous pharmacotherapy. In addition, they must be in possession of a certiﬁ cate 
entitling them to undertake these tasks (For more information, see Chapter 5.4 
Certiﬁ cation). Licensed healthcare professionals with pharmacotherapy training 
are allowed to administer central nervous system agents in accordance with the 
principles outlined in Table 8. 
In addition to licensed healthcare professionals, professionals with protected 
occupational titles (as deﬁ ned in the Act on Healthcare Professionals) trained in 
pharmacotherapy can dispense and administer non-parenteral medications. In ad-
dition, they can administer intra-muscular and subcutaneous injections provided 
that their knowledge and skills have been veriﬁ ed, they have received the appro-
priate induction training and are in possession of a written certiﬁ cate entitling 
them to undertake the task in question. Healthcare professionals with protected 
occupational titles who have received pharmacotherapy training can also change 
ﬂ uid bags provided they contain no medication and commence ﬂ uid therapy in 
an emergency situation, where no licensed healthcare professional with phar-
macotherapy training is available. Professionals with protected occupational ti-
tles who have received pharmacotherapy training are also authorized to admin-
ister adrenaline and subcutaneous colloid and crystalloid treatment in the event 
of cardiac arrest where no licensed healthcare professional is available. In addi-
tion, healthcare professionals with protected occupation titles who have received 
pharmacotherapy training may participate in the administration of non-parenter-
al medications affecting the central nervous system. As before, regular veriﬁ cation 
of skills and knowledge, further training and written certiﬁ cation are required. 
The above principles apply to the provision of pharmacotherapy in emergen-
cy care with the exception of rescue staff and ﬁ re ofﬁ cer-ambulance attendants 
without pharmacotherapy training who participate in the administration of ba-
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sic drug therapies. Their skills and knowledge must be veriﬁ ed and they must be 
provided with training in accordance with the above requirements. There will be 
a ﬁ ve-year transitional period, during which all staff participating in the provision 
of advanced pharmacotherapy must have obtained a healthcare qualiﬁ cation in-
corporating pharmacotherapy training that is equivalent to the basic qualiﬁ cation 
undertaken by licensed healthcare professionals. With regard to emergency care, 
the skills requirement must be observed earlier. In addition, skills veriﬁ cation 
processes must be developed to reﬂ ect the level of pharmacotherapy provided. 
The lines of accountability described above also apply to the provision of phar-
macotherapy services in social care units and service environments where phar-
macotherapy is not routinely carried out. Overall responsibility rests with the 
unit medical director. The responsibility for pharmacotherapy provision rests 
with a healthcare professional with pharmacotherapy training. The doctor is re-
sponsible for prescriptions and prescription accuracy. Employees distributing and 
administering medications are responsible for ensuring that these tasks have been 
carried out in accordance with instructions provided by the prescribing doctor. 
Thus, staff participating in the provision of pharmacotherapy are responsible for 
their own actions. A social care professional trained in pharmacotherapy may ad-
minister non-parenteral medications. They may also administer subcutaneous in-
jections, subject to further training, skills veriﬁ cation and certiﬁ cation. 
Joint working with healthcare professionals trained in pharmacotherapy is par-
ticularly important for staff in service environments where pharmacotherapy is 
not routinely carried out. Staff with no training in pharmacotherapy may par-
ticipate in the administration of non-parenteral medication and sub-cutaneous 
injections in exceptional cases only or on a case-by-case basis and following ap-
propriate further training. Training can only be provided by a licensed health-
care professional and the certiﬁ cate issued by the medical director. Skills must be 
regularly veriﬁ ed. The training organiser is responsible for training quality, the li-
censed healthcare professional for ensuring that sufﬁ cient proof of skill has been 
provided and the certifying doctor for determining task-speciﬁ c minimum skill 
and training requirements. The provision of pharmacotherapy in these instances 
is based on an agreement between the patient and/ or their next of kin, the ad-
ministering staff and the unit management/ senior staff. Staff administering phar-
macotherapy are responsible for their own actions when undertaking this activ-
ity. The employer is responsible for ensuring that the service provided complies 
with all relevant legislation. 
Appropriate further training is deﬁ ned as training that equips the trainee to un-
dertake the tasks in question. Such training qualiﬁ es the employee to participate 
in pharmacotherapy activities at the level pharmacotherapy is provided at their 
unit of employment. Job descriptions and pharmacotherapy responsibilities, del-
egation procedures and multi-disciplinary working are detailed in the pharmaco-
therapy plan. 
Students studying for a basic vocational qualiﬁ cation in social and health and 
social care (practical nursing qualiﬁ cation) and undertaking work placements are 
to be provided with training that is suited to their level of training under the im-
mediate guidance and supervision of their placement supervisor. Placement su-
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pervisors are responsible for the work carried out by the students. Nursing, public 
health nursing, paramedicine and midwifery students undertaking polytechnic-
level qualiﬁ cations also participate in the administration of more advanced phar-
macotherapy, including intravenous ﬂ uid and drug therapies and cannulation 
under the guidance and supervision of their designated supervisors. Supervisors 
must be qualiﬁ ed to administer the relevant drug therapies. The supervision of 
students is carried out in accordance wíth recommendations issued by the Minis-
try of Social Affairs and Health (Heinonen 2003). 
Participation in supervised placements and on the job training is subject to the 
students having obtained the necessary theoretical knowledge and skills as well 
as proﬁ ciency in drug calculations. Students must be able to demonstrate the ex-
tent of their pharmacotherapy studies and passes obtained in pharmacotherapy 
and drug calculcations, if so requested by the unit. Agreements between training 
organisers and educational institutions concerning supervised training and on the 
job training must take account of the level of skill required of students, the extent 
to which they will participate in pharmacotherapy provision during their place-
ment and the learning aims. Where a student temporarily undertakes the duties 
of a healthcare professional, the employer must determine the extent to which 
the student can participate in pharmacotherapy provision taking into account the 
student’s skills and the level of pharmacotherapy provided at the unit . 
It is appropriate for health and social care units to utilise pharmacological and 
pharmaceutical expertise (head dispensers, pharmacists) and for each team to 
have in place a designated pharmacology co-ordinator. Both play a key role in the 
provision and development of the pharmacotherapy service offered by the unit. 
Ward pharmacy specialist knowledge can be utilised, for example, by appointing 
a rotating pharmacist. Social care and out-patient units can make use of this by 
developing their co-operation with community pharmacies. ( See Chapter 5.5 
Pharmaceutical services.) Table 7 sets out the staff whose duties and responsi-
bilities are deﬁ ned in the health and social care / work unit or team pharmaco-
therapy plan.
Tab 7. Staff providing pharmacotherapy and their duties
Deﬁ ning the duties and responsibilites of staff participating in the planning, • 
organisation and provision of pharmacotherapy: 
Health and social care unit and/ or work unit management• 
Medical/ Nursing Director• 
Senior doctor and senior nurse• 
Pharmacotherapy clinical lead• 
Licensed healthcare professionals trained in pharmacotherapy• 
Professionals with protected occupational titles trained in • 
pharmacotherapy
Social care professionals trained in pharmacotherapy• 
Temporary staff• 
Staff not trained in pharmacotherapy• 
Trainee students or students temporarily employed as healthcare • 
professionals
Task allocation, delegation and multi-disciplinary working• 
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Table 8 sets out staff capacities and skills for participating in pharmacotherapy 
provision on the basis of current qualiﬁ cation requirements. For more detailed in-
formation on staff providing pharmacotherapy, please see Fig 10.
Tab 8. Staff capabilities and skills for participating in pharmacotherapy provision on the 
basis of current qualifi cation requirements
Staff providing 
pharmacotherapy
Skills obtained through 
basic education
Verifying skills, further 
training
Responsibility/ 
certiﬁ cation
Licensed healthcare 
professionals trained in 
pharmacotherapy
ordering, storing • 
and preparation and 
dispensing of medicines, 
non-parenteral medicines• 
intradermal, sub-• 
cutaneous and intra-
muscular injections 
vaccinations• 
intravenous ﬂ uid and • 
drug therapies
participation in epidural • 
injections
intravenous ﬂ uid and • 
drug therapies
participation in • 
epidural injections, 
including PCA
vaccinations• 
Certiﬁ cation: Health 
and social care Unit 
Medical Director or 
delegated doctor
Proof of competence: 
Experienced licensed 
healthcare professional
Healthcare professionals 
with protected 
occupations titles trained 
in pharmacotherapy
dispensing of medicines• 
non-parenteral • 
medications
subcutaneous and • 
intramuscular injections
ordering of medicines• 
subcutaneous and • 
intramuscular injections
changing non-• 
medicated continued 
infusion liquids and 
bags of ﬂ uid
emergency care, see • 
Appendix 8 
Certiﬁ cation: Health 
and social care Unit 
Medical Director or 
delegated doctor
Skills test: Licensed 
healthcare professional 
Social care 
professionals trained in 
pharmacotherapy
administration of • 
dispensed non-parenteral 
medications 
dosing of medicines at • 
the patients home
subcutaneous injections • Certiﬁ cation: Health 
and social care Unit 
Medical Director or 
delegated doctor
Skills test: Licensed 
healthcare professional 
Staff not trained in 
pharmacotherapy
administration of non-• 
parenteral medicines in 
patient-speciﬁ c doses 
subcutaneous injections• 
dosing of medicines at • 
patients home
As agreed
patient, medications • 
and situation-speciﬁ c
Certiﬁ cation: 
Operational Unit 
Medical Director or 
delegated doctor
Skills test: Licensed 
healthcare professional
Students students required • 
to present proof of 
pharmacotherapy studies 
training provider and • 
education institution 
to agree on placement/ 
work placed learning 
content
employer • 
representative 
(pharmacotherapy 
clinical lead or 
ward manager) 
assesses the students 
pharmacotherapy 
skills and 
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5.4 Certifi cation procedures
The pharmacothrerapy plan sets out certiﬁ cation procedures entitling holders to 
different levels of pharmacotherapy practice and related communications strat-
egies. All operational units providing pharmacotherapy services are required to 
implement certiﬁ cation and skill veriﬁ cation procedures. The registration of phar-
macotherapy certiﬁ cates can be linked to the further training register and ex-
panded to a regional, hospital district or health board level service. This facilitates 
the movement of staff between units. 
The pharmacotherapy plan sets out the levels of pharmacotherapy practice 
and deﬁ nes situations where pharmacotherapy certiﬁ cation is required in addi-
tion to the professional qualiﬁ cation and pharmacotherapy studies. The plan al-
so speciﬁ es medications, which are subject to certiﬁ cation and those that can be 
administered without consultation with a doctor. Pharmacotherapy certiﬁ cation 
is unit-speciﬁ c. The pharmacotherapy plan will also specify certiﬁ cation scope as 
certiﬁ cates can also be issued on a team-, drug- or patient-speciﬁ c basis. The plan 
must also account for certiﬁ cates entitling staff to place medication orders. Certif-
icates entitling staff to practice pharmacotherapy will be stored at the health and 
social care and/ or team unit. Ease of access must be ensured to facilitate the ﬂ ow 
of information and smooth service delivery. All staff practicing pharmacotherapy 
must hold copies of all valid certiﬁ cates issued to them. Veriﬁ cation of theoretical 
skills is by regular written examination. Practical skills are veriﬁ ed by skills exam-
ination. The development of electronic learning environments has made useful 
skill updating and testing tools available. 
The administration of intravenous ﬂ uid and drug therapies, other advanced 
pharmacotherapy procedures is always subject to further training, skills veriﬁ ca-
tion and certiﬁ cation by the health and social care unit medical director. Intrave-
nous drug administration and other advanced pharmacotherapy skills are veriﬁ ed 
at the unit where the employee is based. Veriﬁ cation should be carried out regu-
larly, approximately every 2-5 years depending on the health and social care unit 
and/ or team pharmacotherapy requirements and the level of skill required. In-
travenous injection and vaccination skills are subject to veriﬁ cation and certiﬁ ca-
tion. Certiﬁ cates must be issued in the unit where the employee is based. Further 
training must be made available where required. 
Intramuscular and subcutaneous injection skills (with the exception of licensed 
healthcare professional trained in pharmacotherapy) are subject to veriﬁ cation 
and certiﬁ cation issued in the unit where the employee is based. Further training 
must be made available where required. Setting out certiﬁ cation procedures for 
the administration of non-parenteral medications is particularly important in so-
cial care units and service environments where pharmacotherapy is not routine-
ly carried out. Administration of non-parenteral medicines by staff who are not 
health and social care professionals trained in pharmacotherapy is subject to veri-
ﬁ cation, appropriate training and certiﬁ cation by the unit medical director. Table 
9 sets out the main points regarding certiﬁ cation.
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Tab 9. Certifi cation procedures
S• kills obtained through basic training and their assessment
Level of expertise: identifying additional skill and knowledge requirements• 
Further and other additional training, skills test and certiﬁ cate• 
Certiﬁ cate to undertake additional tasks • 
Deﬁ nition of pharmacotherapy procedures/ medications/ patient groups • 
requiring certiﬁ cation
Period of validity and re-validation• 
5.5 Pharmaceutical services
The pharmacotherapy plan is required to cover key pharmaceutical services such 
as medical stock management and the ordering, storage, preparation, return and 
disposal of medicines. In addition, the plan takes account of the role of phar-
maceutical services in the provision of guidance and information on medicines 
Pharmaceutical services are provided in accordance with relevant administrative 
regulations issued by the National Agency of Medicines (5/2001 and 5/2002). 
Pharmaceutical staff expertise is used to inspect health and social care unit medi-
cal supplies and cabinets. Ward pharmacists improve the availability of medicines 
and the monitoring and recycling of medicines approaching their use-by date. In 
order to ensure cost-effective and safe pharmacotherapy provision, it is advisable 
for each operational unit to have in place an expert group representing the differ-
ent medical specialties and having knowledge of the Finnish current care guide-
lines, which together with the hospital pharmacy or medicine centre can deter-
mine the unit’s basic formulary. The group will work to harmonise and guide the 
acquisition and use of medicines at the unit. Formulary criteria include safety and 
appropriateness. Social and healthcare units obtain their stocks through the hos-
pital pharmacy, the medicine centre or a community pharmacy. Medications re-
quiring specialist skills and/ or equipment due to their state or handling require-
ments (including radiopharmaceuticals and medical gases) can be purchased and 
delivered directly to the unit using them in accordance with instructions provid-
ed by the hospital pharmacy or medicine centre. Hospital pharmacies and med-
icine centres supply medicines to the wards and other operational units on the 
basis of a written, electronic or faxed order form. If the order is placed verbally 
or over the phone, it should be conﬁ rmed at the earliest possible opportunity in 
writing, electronically or by fax. Pharmaceutical staff must make sure the au-
thenticity of the orders and deliveries and to clarify any problems prior to deliv-
ery. The pharmacotherapy plan must specify what qualiﬁ cations and training are 
required for ordering formulary medicines from the hospital pharmacy or medi-
cine centre. When ordering non-formulary medicines or medicines whose release 
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is subject to a special permit from the National Agency of Medicines (excluding 
medicines subject to a limited period permit), the order must be countersigned 
by the doctor-in-charge or other delegated doctor. An order for narcotic substanc-
es or alcohol must be countersigned by the doctor in charge of the ward or unit, 
or other delegated doctor. Narcotic substances and alcohol can only be supplied 
on the basis of an order submitted in writing. Medicines are to be delivered in 
their original packaging. The original packaging should not be split unless there is 
express reason to do so. 
Whenever possible, medicines are prepared for use in the hospital pharmacy 
or medicine centre. However, the medicine can also be prepared for use on the 
ward, in another health and social care unit or at the patient’s home, in which 
case written instructions from the community pharmacy, hospital pharmacy or 
medicine centre must be followed. The environment and location in which med-
icines are prepared must be suitable and ﬁ t for purpose. As a rule, medicines 
should be prepared for use in an area that has been especially designed for this 
purpose and where suitable controls are in place. Manufacturer or marketing au-
thorisation holders’ instructions must be followed when preparing medicines for 
use. Particular care should be taken to ensure that correct working methods (e.g. 
aseptic techniques) are employed and potential incompatibilities with regard to 
medicines, solutions and packaging materials are considered. The microbiologi-
cal and chemical preservability should be observed when preparing medicines for 
use. Particular care should be taken when handling sterile pharmaceutical prod-
ucts. In addition, practitioners should ensure that the correct storage, usability 
window and documentation procedures are followed. Instructions should also be 
followed when medicines are prepared for use in the domiciliary care context. 
Where pharmaceutical products pose a hazard for the operator or the patient 
(e.g. radiopharmaceuticals and cytotoxic medications), health and safety legisla-
tion and standards must be adhered to. 
Stock monitoring arrangements should be in place to ensure that medicines 
that are out of date or otherwise unsuitable for use are immediately removed. Un-
der Finnish waste legislation all medicinal waste is classiﬁ ed as hazardous waste 
and must be handled in accordance with local authority instructions. Medicines 
stored on the wards or at other health and social care units that are unused, out 
of date, banned or otherwise unsuitable for use must be returned to the hospital 
pharmacy or medicine centre. Please note that medicines stored at the patient’s 
home or in units purchasing medicines through a community pharmacy that are 
out of date, unsuitable for use, no longer required or classed as a narcotic should 
be returned to the community pharmacy. 
Annual ward visits conducted by the hopital pharmacy and medicine centre 
are designed to ensure that drug safety and appropriate procedures and working 
methods are observed on the wards and other units. The visits may be conducted 
less frequently in exceptional circumstances or where appropriate, for example, 
where the storage and handling of medicines is limited and no particular prob-
lems have been identiﬁ ed. 
Medicines at the health and social care and/ or work unit should be stored in 
an area that can be locked and is sufﬁ ciently spacious and ﬁ t for its purpose. En-
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suring that medicines with a similar apperance or purpose are stored separately 
in different areas reduces the risk of error and enhances patient safety. Medicines 
should be stored separately from other products and equipment. Particular care 
should be taken to ensure that correct storage conditions are observed. Stocks 
should be checked regularly by the work unit staff to ensure that medicines are 
not out of date or otherwise unsuitable for use. Key handling and access priv-
iledges should be arranged in such a way as to prevent unauthorised access to the 
medicine cabinet or store. Particular care should be taken with medicines that are 
subject to misuse. Where misuse is suspected, the hospital pharmacy, medicine 
centre and management or security department should be contacted. 
Medicines required in the provision of emergency care can be stored outwith 
the medicine cabinet or store in the treatment room or as part of ambulance 
or other ambulatory emergency care staff equipment. In the “hospital at home” 
context, medicines administered in the patient’s home can be stored as part of 
the health care unit equipment. Medicines requiring specialist storage should be 
checked regularly. Particular care should be taken to ensure that they are ﬁ t for 
use and readily accessible. With regard to illicit narcotics and central nervous sys-
tem agents, the Narcotics Act and related standards must be observed. Table 10 
sets out the key points on pharmaceutical services.
Tab 10. Pharmaceutical services
Unit formulary• 
Ordering and delivery of medicines• 
Storage of medicines, storage areas and monitoring of storage • 
conditions
Manufacture and preparation for use• 
Return and disposal of medicines• 
Pharamaceutical information• 
Pharmaceutical guidance and advice• 
5.6 Distribution and administration of medicines
As a rule, medicines are distributed in accordance with the original prescription. 
The distribution of medicines should be carried out in areas and conditions that 
are ﬁ t for purpose. A calm working environment prevents medication errors and 
promotes patient safety. Double-checking is recommended for medicine prepa-
ration to reduce the occurrence of errors. Already prepared medicines are to be 
stored in locked areas and clearly labelled to prevent errors during administra-
tion.
The pharmacotherapy plan should incorporate measures for ensuring the co-
rrect dosing/ administration of medicines. These measures include the documen-
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tation of the patient’s name and required time of administration on the container. 
Automated drug distributions systems can be particularly useful in health and so-
cial care and work units where few staff are trained in drug distribution. Suitable 
and appropriate working methods and equipment should always be employed. In 
addition, all relevant administrative regulations and normative guidelines must be 
observed. Staff are also responsible for observing the effects of the administered 
medication. Table 11 sets out the key points on the distribution and administra-
tion of medicines.
Tab 11. Distribution and administration of medicines
Carried out in accordance with the original written/ electronic • 
prescription
Appropriate storage areas and distribution conditions • 
Double-checking of medicines before administration• 
Unit dose drug distribution systems• 
Storage of distributed medicines• 
Unit dose (e.g. medicine container) documentation requirement• 
 Double checking dosage prior to administration• 
Identifying patient prior to administration• 
Monitoring medicine effects• 
5.7 Patient information and advice
The pharmacotherapy plan sets out guidelines on the provision of information 
and guidance to the patient and their representative, including verbal and written 
instructions and monitoring instructions. The doctor, the administering staff and 
the pharmaceutical staff are required to provide information and offer guidance 
and instruction to the patient in all pharmacotherapy-related matters throughout 
the treatment process. This allows the patient to take part in the planning, ad-
ministration and assessment of their drug treatment. It is particularly important 
to ensure that the patient has understood the information provided to them. The 
provision of information and guidance is designed to support treatment compli-
ance. The patient must always be informed of any medication errors and adverse 
effects that may have occurred or may occur in future. Table 12 sets out key 
points on the patient information and advice.
Tab 12. Informing and advising patients
P• atient participation and treatment compliance
Provision of information• 
Guidance and instruction (verbal/ written)• 
Ensuring patient has understood instructions provided• 
Informing patient of medication errors• 
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5.8 Evaluating treatment effectiveness
The pharmacotherapy plan sets out the procedures for assessing the effectiveness and ap-
propriateness of treatment at the health and social care unit. The assessment of effective-
ness encompassess the monitoring and assessment of expected therapeutic effects, poten-
tial side effects and adverse effects and drug interactions. When issuing a prescription, the 
doctor must ensure that the person administering the medication is aware of effects that 
require monitoring during and after administration. In addition, the plan should cover 
the documentation and reporting of drug effects. The plan also determines the situations 
where a doctor should be informed and consulted. These include situations where the pa-
tient is unintentionally administered the wrong medication. The doctor will carry out a 
regular review of the patient’s drug therapy needs and adjust treatment as required. Ta-
ble13 sets out the key points regarding effectiveness assessments.
Tab 13.  Evaluating pharmacotherapy effectiveness 
Appropriateness of pharmacotherapy• 
Expected beneﬁ ts and therapeutic effects• 
Side and adverse effects• 
Interactions• 
Drug overlaps• 
Monitoring of effects • 
Procedures in case of incorrect administration or dosage• 
Regular review of drug treatments• 
5.9 Documentation and information fl ow
Establishing good documentation practices is a key function of the pharmaco-
therapy plan. Health and social care units must comply with legislation on docu-
mentation and recordkeeping (Act on the Status and Rights of Patients 785/1992, 
Ministry of Social Affairs and Health Decree on the Creation and Storage of 
Health Records 99/2001 (available in Finnish and Swedish only)). Particular em-
phasis should be placed on the health and social care/ work unit documentation 
practices and their implementation. Particular care should be taken to ensure that 
when consulting or reporting to the doctor, the discussions and the time they take 
place are appropriately recorded. 
The pharmacotherapy plan must take account of pharmacotherapy continui-
ty and information ﬂ ow with due regard for data protection measures. Particular 
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emphasis should be placed on working practices that promote the updating of 
patient medicine lists in order to prevent drug overlaps, adverse interactions and 
attendant problems. The accuracy of the list of medicines is to be veriﬁ ed when 
the patient is discharged. Table 14 sets out the key points on documentation and 
information ﬂ ow.
Tab 14. Documentation and information fl ow
Recordkeeping• 
Pharmacotherapy follow-up plan• 
Information ﬂ ow between units• 
Data protection issues• 
Accurate and current medication lists: allergies, interactions, overlaps• 
5.10  Monitoring and feedback systems 
Information generated through the monitoring and feedback systems supports 
operational development. Pharmacotherapy service provision is monitored regu-
larly at the health and social care work unit level in accordance with the phar-
macotherapy plan. Error reporting is central to the pharmacotherapy plan. Steps 
must be taken to ensure that medication errors are monitored, followed up and 
learned from. Health and social care units are required to introduce standard 
medication error reporting forms. In future, a national electronic register can be 
used to facilitate learning. 
Particular emphasis should be placed on maximising opportunities for learning 
from errors and feedback. Reporting systems work best in organisations where 
the atmosphere is open and constructive and the focus is on learning and follow-
up. The plan must also set out the process for notifying patients of medication 
errors. Patients must, at a minimum, be notiﬁ ed of all errors that have or may ha-
ve serious consequences. Table 15 sets out the key points on monitoring and fee-
dback systems.
Tab 15. Monitoring and feedback systems
Error reporting and documentation • 
Patient notiﬁ cation• 
Error reporting systems• 
Monitoring and follow-up • 
Making use of feedback• 
Learning from errors and adjusting working methods• 
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Drug safety is kept under constant monitoring and review. Data on adverse reac-
tions occurring in Finland is gathered in the national adverse reactions register. 
Doctors and dentists are encouraged to report all conﬁ rmed or suspected adverse 
drug reactions. Adverse drug reactions are reported to the National Agency of 
Medicines using the prescribed form (available from the internet at
www.laakelaitos.ﬁ /uploads/lomakkeet/Haittavaikutusilmoitus.pdf). More de-
tail on the reporting of adverse effects is available from the National Agency of 
Medicines guideline (1/2005), in effect until the end of 2010. 
The Medical Devices Act (1505/1994, 345/2000 as amended, available in Fin-
nish and Swedish only) requires all patient safety incidents resulting from the 
professional use medical devices to be reported to the National Agency of Medi-
cines. The Act also requires all social and helthcare operational units to have in 
place a system for the recording and handling of patient safety incidents resul-
ting from the use of medical devices. (National Agency of Medicine Guidance 
4/2005, available in Finnish and Swedish only.)
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6 AGENTS ACTING ON THE CENTRAL 
NERVOUS SYSTEM 
AND ACTUAL NARCOTICS 
A list of agents acting on the central nervous system (CNS agents) is provided 
by the National Agency of Medicines. Due to their pharmacological properties, 
both CNS agents and actual narcotics are classiﬁ ed as having potential for mis-
use (National Authority for Medicolegal Affairs 2002). To prevent abuse, it is im-
portant to ensure that the prescription is medically indicated, current and recent 
medications are reviewed to prevent interactions, that communication between 
the patient, the doctor and the pharmacy is improved and the effectiveness of 
the treatment is assessed prior to the issuing of another prescription. CNS agents 
may impair performance in trafﬁ c. A red triangle and the text “May impair per-
formance in trafﬁ c” are displayed on their packaging. Table 16 contains examples 
of CNS agents.
Tab 16. CNS Agents (Agents acting on the central nervous system)
CNS-t Ordinary medications containing CNS agents, including 
benzodiazepines, sedatives and hypnotics and analgesia 
containing codeine
CNS-a Medications containing CNS agents available on one-off 
prescription only (as deﬁ ned in the Decree on Prescriptions 
726/2003, available in Finnish and Swedish only), including 
opiates and moderate analgetics 
Patient consent for the sharing of CNS medication information is currently be-
ing obtained in too infrequently. Consent can be obtained at the doctor’s surgery, 
clinic etc or at the pharmacy using a form authorised for use by the data protec-
tion ombudsman. By signing the form, the patient commits to obtaining their 
medication from one surgery or other healthcare unit and one pharmacy only. 
Other pharmacies can be notiﬁ ed of the arrangement. 
Actual narcotics are deﬁ ned as substances contained in Schedules I, II and IV of 
the Single Convention on Narcotic Drugs 1961 and in Schedules I and II of the 
Convention on Psychotropic Substances 1971 (including morphine, methadone, 
fentanyl, sufentanil and pethidine). In in-patient care, the consumption of the 
above medicines is tracked using a package-speciﬁ c consumption sheet. Medici-
nes classed as actual narcotics can only be prescribed to out-patients using a de-
signated narcotics prescription form that is retained by the pharmacy. Medicines 
containing actual narcotics can be ordered to healthcare institutions with a me-
dicine order.  The Ministry of Social Affairs and Health Decree on the Prescrip-
tion of Medicines (726/2003, available in Finnish and Swedish only) lays down 
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provisions on the ordering of medicines and the prescription of CNS agents and 
actual narcotics. 
When actual narcotics are supplied to a social or healthcare unit, each packa-
ge must be accompanied with a consumption sheet speciﬁ ying the name of the 
product, amount, date of delivery and name of the ward or operational unit. The 
name of the patient, the amount administered, the name of the doctor and per-
son administering the medication and the date must be documented on the sheet. 
When the contents of the package have been used up, the consumption sheet 
along with details of any accidental wastage must be signed off by the doctor in 
charge of the unit or another authorised doctor and returned to the pharmacy, 
the hospital pharmacy or medicine centre. 
Particular care should be taken when administering CNS agents and actual nar-
cotics in the hospital as fatal medication errors are possible. Wherever possible, 
PCA infusions and titrations must be prepared at the hospital pharmacy or by the 
ward pharmacist. It is recommended that the dosing of narcotic agents is double-
checked by another member of staff and that staff administering them are trained 
to observe their effects. (Paaskoski 2004.)
In domiciliary care, particular care should be taken to ensure that the patient, 
family care givers and personal assistants are given sufﬁ cient guidance and advice 
to prevent unauthorised access to the patient’s medicines (Pennanen 2004). The 
importance of keeping these medications away from third parties in the interests 
of abuse prevention should be particularly emphasised. Table 17 sets out key po-
ints on CNS agents and narcotics.
Tab 17. CNS agents and narcotics
Therapeutic use • 
Clinical indication• 
Prescription• 
Communication between patient, doctor and pharmacy• 
Prescription and record-keeping procedures• 
Evaluating effectiveness• 
Pharmacy supply procedures• 
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7 REHABILITATION, REPLACEMENT AND 
MAINTENANCE THERAPY FOR OPIATE 
DEPENDENCE 
The use of buprenorphine and methadone for opiate withdrawal, replacement 
and maintenance therapy is regulated by the Ministry of Social Affairs and Health 
Decree 289/2002. As a rule, indications for treatment should be assessed and 
treatment initiated in a hospital setting. Administration can be continued in co-
operation with a municipal federation hospital district unit, health centre, sub-
stance abuse unit or prison service healthcare unit with sufﬁ cient resources in 
place. All units administering this treatment must appoint a named lead clinician 
to oversee the service and notify the relevant state provincial ofﬁ ce of the ap-
pointment. The state provincial ofﬁ ce is responsible for registering the unit and 
the lead clinician with the National Authority for Medicolegal Affairs. As the 
treatment of opiate dependence requires specialist skills, the National Authority 
for Medicolegal Affairs requires all private units administering this treatment to 
obtain a private healthcare service provider licence from the relevant state pro-
vincial ofﬁ ce. The treatment of opiate dependence should be based on a sepa-
rate treatment plan covering both medical and psychosocial treatment and their 
monitoring. The above medicines can only be prescribed and ordered by the lead 
clinician or delegated doctor. The medicines cannot be prescribed through the 
pharmacy. They must be administered in a controlled environment in the rel-
evant unit. However, patients demonstrating good compliance can be supplied 
medicines up to the equivalent of an eight-day supply. 
The procedures for the ordering and documenting of the above medicines are 
set out in the Decree on Prescriptions 726/2003 (available in Finnish and Swe-
dish only). They must be stored in a cabinet or area that is secured by a lock. Best 
record-keeping practice must be observed. This is to ensure that no personal me-
dications are allocated and no medications are left unadministered. The medici-
nes can be administered by a healthcare professional or social care professional 
with sufﬁ cient training in pharmacotherapy. Administration must be documen-
ted in the patient records. Table 18 sets out the key points on rehabilitation, re-
placement and maintenance therapy for opiate dependence.
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Tab 18. Rehabilitation, replacement and maintenance therapy for opiate dependence
Therapeutic use of medicines• 
Ensuring availability of sufﬁ cient resources • 
Assessing indication for treatment• 
Preparation of treatment plan• 
Ordering and storage of medicines• 
Administration of medicines• 
Record-keeping• 
Evaluating treatment effectiveness• 
References
Finlex – Finnish legislation online. http://www.ﬁ nlex.ﬁ /ﬁ /.
52 Safe Pharmacotherapy
National Guide for Pharmacotherapy in Social and Health Care
Appendix 1. Pharmacotherapy in social and 
healthcare working group
Chair:
Pirjo Pennanen, Medical Counsellor, National Authority for Medicolegal Affairs
Vice-Chair:
Marjukka Vallimies-Patomäki, Ministerial Adviser, Ministry of Social Affairs and Health
Members:
Counsellor Eija Koivuranta, Ministry of Social Affairs and Health, until 15 May 2005
Counsellor Riitta-Maija Jouttimäki, Ministry of Social Affairs and Health, from 16 May 2005 
Viveca Arrhenius, Ministerial Adviser, Ministry of Social Affairs and Health
Terttu Jääskeläinen, Counsellor of Education, Ministry of Education
Riston Suominen, Senior Pharmaceutical Ofﬁ cer, National Agency for Medicines
Antti Laine, Provincial Medical Ofﬁ cer, State Provincial Ofﬁ ce of Southern Finland
Synnöve Amberla, Ministerial Adviser, Association of Finnish Local and Regional Authorities
Jouni Kurola, Medical Specialist, Kuopio University Hospital
Kaija Heikura, Chief Executive, Hospital District of Souther Karelia
Markku Mattila, City of Oulu Social and Healthcare Service
Sari Ahonen, Head of Department, City of Turku Social Services
Jaana Lehtomäki, Hospital Pharmacist, Turku University Hospital
Expert members:
Seija Ginström, Senior Doctor, Finnish Medical Association
Tuula Pitkänen, Union of Health and Social Care Professionals (Tehy)
Marita Ritmala-Castrén, Finnish Nursing Association
Raija Moilanen, Finnish Union of Practical Nurses
Harri Ovaskainen, Pharmaceutical Director, Finnish Pharmacists’ Association 
Sari Laaki, Regional Planner, Talentia
Kaijamaija Parviainen, Education Planner, Trade Union for the Public and Welfare Sectors
Secretariat:
Riitta Aejmelaeus, Medical Director, Centre for Pharmacotherapy Development ROHTO 
Anne Markkula, Midwife, Student
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Appendix 2. Verbal consultation and written evidence
24 May 2005 
Oral evidence received from:
Sirpa Peura, Pharmaceutical Director, Association of Finnish Pharmacies• 
Jari Vepsäläinen, Provincial Medical Ofﬁ cer, State Provincial Ofﬁ ce of Eastern • 
Finland
Markku Poutala, Assistant Head of Department, Trade Union of Education • 
in Finland
Anneli Juutinen, Director, Finnish Patients’ Association• 
Sirkka Keikkala, Medical Director, Jyväskylä Social and Healthcare Service • 
Centre
Seija Piirainen SHJ, SHO, Midwife, Association of Finnish Midwives• 
Councillor Kirsti Riihelä, Provincial Medical Ofﬁ cer, Member of Advisory • 
Board for Health and Welfare in Emergency Conditions, Emergency Care 
and Training Committee
Martti Heinonen, Legal Counsel, Pharma Industry Finland• 
Eeva-Liisa Urjanheimo, Chair, Public Health Nurses Association in Finland• 
Teuvo Kontio, Chair, Finnish Ambulance Attendants’ Association• 
Sirkka Lappalainen, Chair, Network of Health Polytechnics• 
Ritva Korte, Director of Education, Social and Healthcare Education Network• 
Written statements:
Esa Ahonen, Director of Medicine, Kainuu Municipal Federation• 
Ann-Marie Turtiainen, Chair, Health academic leaders and experts• 
Marja-Liisa Kunnas, Director, Association for Old Age and Neighbour Service• 
Aki Linden, Hospital District Director, Turkka Tunturi, Medical Director, • 
Intermunicipal Hospital District of Southwest Finland
Sinikka Koskinen PhD MD, Specialist in Internal Medicine, Finnish Red • 
Cross
Counsellor Kirsti Riihelä, Senior Inspector Pirjo Partanen, State Provincial • 
Ofﬁ ce of Southern Finland
Maaret Castrén, Medical Director, Emergency Care Division, Hospital • 
District of Helsinki and Uusimaa
Oili Kärkkäinen, Director of Service Development, Hospital District of • 
Helsinki and Uusimaa
Ilkka Kunnamo, Doctor of Medicine and Surgery, Päivi Koikkalainen, Inter-• 
municipal Hospital District of Saarijärvi-Karstula 
Kim Nikula, Chair, Finnish Association of Fire Fighters SPAL• 
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